Bionnovation Biomedical
Bionnovation Biomedical is a Brazilian medical device company that manufactures and distributes bone regeneration biomaterials, membranes, fixation devices, and dental implants to dental and oral surgery professionals across five continents.
- Company typePrivate
- Founded1993
- HeadquartersSalvador, Brazil
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bionnovation Biomedical does
Bionnovation Biomedical is a Brazilian medical device company headquartered in Bauru, São Paulo, that develops, manufactures, and distributes bone regeneration biomaterials, surgical membranes, fixation devices, and dental implants for dental and oral/maxillofacial surgery. The company's core offering centers on the Bonefill line of xenogenous bovine bone grafts (granulated, block, lamella, and cylindrical variants) and the Surgitime line of resorbable and non-resorbable membranes, complemented by synthetic bone substitutes (hydroxyapatite and beta-TCP), fixation screws, tent screws, tacks, surgical drills, bone collector drills, and graft kits. Products serve dental surgeons, oral surgeons, implantologists, and periodontists performing implant placement, alveolar ridge preservation, sinus lift, periodontal regeneration, and craniomaxillofacial reconstruction.
The company's Bonefill grafts are produced through a proprietary multi-phase purification process that solubilizes organic structures without thermal sintering, preserving the natural interconnected pore structure of bovine bone (Ca/P ratio ~1.67, porosity 65-80%, average pore size 100-600 μm). Bonefill carries a 5-year shelf life versus 2-3 years cited for competing products. Products are registered with Brazil's ANVISA (15+ product codes) and hold CE marking for European market access.
Bionnovation generates revenue through one-time sales of medical devices via an international network of authorized resellers across five continents, with quote-based pricing that is not publicly disclosed. The company supports commercialization through industry events (CIOSP, ROX, IN24, CIOSP25), clinical education programs, professional association partnerships, and multilingual content (Portuguese, English, Spanish). The company was founded in 1993 as Kunzel Brasil Equipamentos Odontológicos Ltda and was transformed and rebranded to Bionnovation Produtos Biomédicos S.A. following an April 2004 investment by US-based Aurora Ventures.
Bionnovation Biomedical firmographics
Firmographics- Name
- Bionnovation Biomedical
- Legal name
- Bionnovation Biomedical LTDA
- Website
- https://bionnovation.com.br
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Bionnovation Biomedical is a Brazilian medical device company that manufactures and distributes bone regeneration biomaterials, membranes, fixation devices, and dental implants to dental and oral surgery professionals across five continents.
- Ownership category
- akta.pro rank
Bionnovation Biomedical industry classification
Industry- Product category
- Dental Bone Regeneration Biomaterials
- NAICS
- Dental Equipment and Supplies Manufacturing (339114), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Dental Equipment & Supplies (3843), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)
- akta.pro secondary industry
- Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH)
Keywords
Where Bionnovation Biomedical is headquartered
LocationHeadquarters
- HQ city
- Salvador
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
Bionnovation Biomedical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Biomaterials and Bone Graft Products: Sale of xenogeneic and synthetic bone graft materials for dental and maxillofacial regenerative procedures. Products include Bonefill granules, blocks, and lamina in various configurations.
- Collagen Membranes: Sale of resorbable collagen membranes (Surgitime Collagen Pericardium) and non-resorbable barriers (Surgitime PTFE, Titanium) for guided bone regeneration.
- Titanium Meshes and Fixation Devices: Sale of titanium meshes (Surgitime Titanium), screws, tent screws, and tacks for bone graft stabilization and fixation.
- Surgical Instruments: Sale of surgical drilling instruments, bone collection drills, and graft kits for regenerative procedures.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels10 records
Bionnovation Biomedical product offering
Product offeringCore offering
Bionnovation Biomedical manufactures and sells a comprehensive line of bone regeneration biomaterials and dental implant products. The portfolio includes xenogeneic bovine bone grafts (Bonefill line in granulated, block, lamellar and cylindrical forms), synthetic bone substitutes (Hydroxyapatite and Beta TCP), resorbable and non-resorbable membranes (Surgitime Collagen, PTFE, Titanium Mesh and Titanium Seal), fixation accessories (graft screws, tent screws, tacks), surgical instruments and grafting kits, and dental implants. Products are sold to dental surgeons, implantologists, periodontists, and oral/maxillofacial surgeons through an international distributor network.
Product overview
Bionnovation Biomedical is a Brazilian medical device company offering a comprehensive portfolio of bone regeneration and dental implant solutions. The product portfolio centers on the Bonefill line of xenogenous bovine bone grafts (available in granulated, block, lamella, and cylindrical forms) as the core product, complemented by synthetic bone substitutes (Hydroxyapatite and Beta TCP), surgical membranes (Surgitime Titanium Mesh, PTFE, Titanium Seal, and Collagen Pericardium), fixation accessories (graft screws, tent screws, and tacks), surgical instruments (cortical drills, bone collector drills, and grafting kits), and dental implants. The products are designed for oral and maxillofacial surgery, implant dentistry, and periodontics, providing solutions for bone grafting, guided bone regeneration, alveolar preservation, and dental rehabilitation.
Differentiator
Problem solved
Functional benefit
Brands
- Bonefill: Xenogeneic bovine bone graft substitute product line including granular, block, cylindrical, and laminar forms derived from bovine femur condyles. Contains Bonefill Denso, Bonefill Mix, and Bonefill Porous variants.
- Surgitime
- Surgitime Collagen
- Surgitime Titanium Seal
Products and services
- Bonefill Xenogeneic Bone Graft Line Xenogeneic bone graft substitute derived from bovine femur condyles, serving as an osteoconductive scaffold for bone regeneration in dental and maxillofacial surgery. Available in granulated (Denso, Mix, Porous with particle sizes 0.10-2.50mm), block (porous cancellous), cortical lamella (25.0 x 10.0mm, 0.9-1.40mm thickness), and cylindrical forms. Multi-phase purification preserves natural bone mineral structure with Ca/P ratio of 1.67, porosity 65-80%, pore size 100-600 μm, BET surface area ~77.5 m²/g, and 5-year shelf life.
- Hidroxiapatita (Hydroxyapatite) Synthetic calcium phosphate bone graft substitute for bone regeneration procedures in oral and maxillofacial surgery. Complements the xenogeneic Bonefill line for clinicians preferring synthetic materials.
- Beta TCP (Beta Tricalcium Phosphate) Synthetic beta-tricalcium phosphate bone graft material for bone regeneration and sinus lift procedures. Synthetic alternative for clinicians and indications where xenogeneic grafts are not preferred.
- Surgitime Titanium Mesh Non-resorbable titanium mesh for guided bone regeneration (GBR) procedures, providing structural support and space maintenance for bone grafts in vertical and horizontal ridge augmentation.
- Surgitime PTFE Membrane Non-resorbable polytetrafluoroethylene membrane for guided bone regeneration, acting as a barrier against soft tissue infiltration into bone graft sites.
- Surgitime Titanium Seal Non-resorbable titanium foil designed for intentional exposure in post-extraction alveolar sealing procedures. Made from commercially pure Grade 1 titanium (ASTM F67), thickness ~0.04mm, 100% waterproof, gamma sterilized. Protects surgical wounds against soft tissue invasion.
- Surgitime Collagen Pericardium Membrane Resorbable acellular bovine pericardium collagen membrane for guided bone regeneration. Natural purified Type I collagen with 19.52 μm average pore size, 3-year shelf life, gamma sterilized. Indicated for implant dentistry, periodontology, and oral and maxillofacial surgery.
- Parafusos de Enxerto (Graft Screws) Bone graft fixation screws available in Regular, Expanded, and Smart configurations with different macro-geometries for various surgical procedures and graft stabilization needs.
- Parafuso Tenda (Tent Screw) Tent screw designed to maintain space under a membrane during bone regeneration procedures, supporting the graft volume and shape.
- Tachinhas (Tacks) Tacks for membrane and graft fixation in bone regeneration procedures. Provides alternative fixation to screws for selected indications.
- Broca Corticale (Cortical Drill) Surgical drill for decorticalization of the recipient site. Made of surgical stainless steel (ASTM F899 440), 1.0mm diameter, available in 3 and 4mm depths, durability ~25 procedures.
- Broca Coletora Triple Blade (Autologous Bone Collector Drill) Triple-blade bone autogenous collector drill with DLC coating, available in 5.0mm and 7.0mm diameters for contra-angle handpiece, providing efficient autologous bone collection during regenerative procedures.
- Kit Enxerto (Bone Graft Surgical Kit) Bone graft surgical kit containing instruments required for bone grafting procedures, packaged as a single offering for clinicians.
- Kit Enxerto Premium Premium bone graft surgical kit with an enhanced instrument set for bone grafting procedures, targeted at surgeons requiring a more complete instrumentation solution.
- Implantes Dentários (Dental Implants) Dental implants offered as part of Bionnovation's portfolio for dental rehabilitation and tooth replacement, including Biomorse XP implants referenced in clinical case studies.
Quantifiable outcome
- Bone healing and integration in minimum 6 months
- +4 more outcomes
Companies that use Bionnovation Biomedical
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles3 records
Bionnovation Biomedical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Bionnovation Biomedical partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered minor.
- Por 1 Sorriso (1 Sorriso)minorSocial impact partnership supporting dental health initiatives. Organization focused on promoting dental care access.
- CBCTBMF - Brazilian Association of Craniomaxillofacial SurgeryminorProfessional association partnership with Brazilian association for craniomaxillofacial surgery, supporting the specialty through educational and professional development initiatives.
- SOBRAPE - Brazilian Association of PeriodontologyminorPartnership with Brazilian periodontology association supporting professional education and research in periodontal regeneration.
- São Leopoldo MandicminorPartnership with São Leopoldo Mandic dental research institution for academic collaboration, research support, and professional education in dental biomaterials.
- Eu ReciclominorEnvironmental sustainability partnership with recycling organization, demonstrating company's commitment to environmental responsibility.
Scale indicators5 records
Recent moves9 records
Expansion highlights5 records
Bionnovation Biomedical competitors and assessment
Company assessmentDirect peers
- Osteogenics Biomedical: US-based regenerative dental products company offering Cytoplast PTFE and collagen membranes, bone graft materials, and fixation hardware — a near-direct line-by-line competitor to Bionnovation's Surgitime membrane and fixation portfolio.
- NovaBone Products: US-based manufacturer specializing in synthetic bioactive bone graft substitutes (calcium phosphosilicate). Comparable in the bone graft substitute and synthetic biomaterial category that Bionnovation competes in with its Hydroxyapatite and Beta TCP lines.
- Botiss Biomaterials: German dental regeneration specialist offering bone grafts (cerabone, maxgraft), collagen membranes (Jason), and soft-tissue matrices. Highly comparable mid-sized European competitor with overlapping xenogeneic and allogeneic graft portfolio plus GBR membranes.
- ZimVie: US-listed dental and spine company with a Regenerative Solutions business ( RegenerOss bone grafts, CopiOs pericardium membrane). Direct comparable in dental bone graft substitutes and resorbable membranes with global distribution.
- Geistlich Pharma: Swiss global leader in dental bone regeneration (Bio-Oss xenograft, Bio-Gide collagen membrane). Most directly comparable to Bionnovation as the dominant incumbent in dental xenogeneic bone grafts that Bionnovation explicitly positions against on microporous structure.
- MIS Implants Technologies: Dental implant manufacturer (Dentsply Sirona group) with V3 and C1 implant systems and a growing regenerative portfolio. Comparable through combined implant-plus-biomaterial positioning for the same oral surgeon and periodontist customers.
- LifeNet Health: Non-profit tissue bank and biologics manufacturer offering allograft and xenograft dental bone grafts (Oracell, OraGraft) plus dental membranes. Comparable regenerative biomaterials portfolio serving the same oral surgery customer base.
Broad incumbents
- RTI Surgical: US-based surgical implant company with a meaningful dental and orthopedic bone graft business (Cortiva, BioAdapt) using both xenogeneic and synthetic materials. Comparable across the bone graft substitute and biologics category.
- Dentsply Sirona: Largest pure-play dental equipment and consumables manufacturer worldwide, including regenerative and implant lines. Broad incumbent whose dental biomaterials portfolio overlaps Bionnovation's regenerative offerings within a much wider product portfolio.
- Straumann: Global leader in dental implants that has expanded into biomaterials (XenoFlex, Membrane Plus) via Straumann Group. Comparable through overlapping regenerative offering plus implants, though at vastly larger scale and broader portfolio.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Bionnovation Biomedical social profiles
Digital presenceBionnovation Biomedical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bionnovation Biomedical leadership team
Management profileNumber of profiles
Bionnovation Biomedical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bionnovation Biomedical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bionnovation Biomedical
What does Bionnovation Biomedical do?
Bionnovation Biomedical manufactures and sells a comprehensive line of bone regeneration biomaterials and dental implant products. The portfolio includes xenogeneic bovine bone grafts (Bonefill line in granulated, block, lamellar and cylindrical forms), synthetic bone substitutes (Hydroxyapatite and Beta TCP), resorbable and non-resorbable membranes (Surgitime Collagen, PTFE, Titanium Mesh and Titanium Seal), fixation accessories (graft screws, tent screws, tacks), surgical instruments and grafting kits, and dental implants. Products are sold to dental surgeons, implantologists, periodontists, and oral/maxillofacial surgeons through an international distributor network.
Is Bionnovation Biomedical a public or private company?
Bionnovation Biomedical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Bionnovation Biomedical founded?
Bionnovation Biomedical was founded in 1993. It employs 101 to 250 people.
Where is Bionnovation Biomedical based?
Bionnovation Biomedical is headquartered in Salvador, Brazil, in the Latin America region.
How does Bionnovation Biomedical make money?
Four revenue lines are on record. Biomaterials and Bone Graft Products are the primary driver. The others are collagen Membranes, titanium Meshes and Fixation Devices and surgical Instruments.
Who are Bionnovation Biomedical's main competitors?
Direct peers on record are Osteogenics Biomedical, NovaBone Products, Botiss Biomaterials, ZimVie, Geistlich Pharma, MIS Implants Technologies and LifeNet Health. Broad incumbents are RTI Surgical, Dentsply Sirona and Straumann.
Does Bionnovation Biomedical have an API?
No public API is recorded for Bionnovation Biomedical.
What industry is Bionnovation Biomedical in?
Bionnovation Biomedical's product category is Dental Bone Regeneration Biomaterials. Its primary akta.pro industry code is HLAHAEAG, Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM), with a secondary code of HLAAAGAH, Cartilage, Bone & Musculoskeletal Regeneration. Its NAICS code is 339114 and its SIC code is 3842.